Abstract
Chapter 19 presents a non-exhaustive list of 111 substances administered in treatment of pediatric cardiac intensive care patients. Relevant pharmacokinetic and pharmacodynamic details are given for the categories drug name, active compound, efficacy, adverse drug reactions (ADR), indications, contraindications, and recommended dosage. Additional tables provide more specifics on the subjects of beta-blockers, nausea, and phenprocoumon. This very comprehensive tabular compendium is a fitting completion of this practical handbook.
The drug list does not claim to be exhaustive. Many of the products are not licensed for pediatrics or the cited indication (off-label). Irrespective of potential differences in pharmacokinetics and pharmacodynamics, many recommendations are oriented on the adult dosages.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Suggested Reading
Munoz R, et al. Handbook of pediatric cardiovascular drugs. Heidelberg: Springer; 2008.
Brunton L, et al. Goodman and Gilman’s the pharmacological basis of therapeutics – 13th edition. New York: McGraw Hill education; 2017.
Vincent J. Dugs and the Kidneys. Clin Pharmacol Ther. 2017;102(3):368–72.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Thul, J., Klauwer, D. (2019). Drug List. In: Klauwer, D., Neuhaeuser, C., Thul, J., Zimmermann, R. (eds) A Practical Handbook on Pediatric Cardiac Intensive Care Therapy. Springer, Cham. https://doi.org/10.1007/978-3-319-92441-0_19
Download citation
DOI: https://doi.org/10.1007/978-3-319-92441-0_19
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-92440-3
Online ISBN: 978-3-319-92441-0
eBook Packages: MedicineMedicine (R0)